SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-052181
Filing Date
2011-10-19
Accepted
2011-10-19 16:08:27
Documents
1
Period of Report
2011-10-17

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c23468_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c23468_4x0.xml 4 4590
  Complete submission text file 0001209191-11-052181.txt   6744
Mailing Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Issuer) CIK: 0001128495 (see all company filings)

IRS No.: 223193172 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address WALKERS SPV, WALKERS HOUSE P.O. BOX 908GT, MARY STREET GEORGE TOWN E9 00000 212-705-8800
QVT Fund LP (Reporting) CIK: 0001290165 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50632 | Film No.: 111148221

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Associates GP LLC (Reporting) CIK: 0001290166 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-50632 | Film No.: 111148222